FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

FDA panel calls to loosen restrictions on testosterone replacement therapy

The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.
STAT

Pharmalittle: We’re reading about FDA plans for CAR-T therapies, skinny drug labels, and much more

In a closely watched case, the U.S. solicitor general urged the Supreme Court to review a controversy over so-called skinny ...
MedPage Today on MSN

FDA Opens Safety Review of Injectable RSV Drugs Approved for Babies and Toddlers

The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs

Conditional approval extended through December 2026 for the treatment of CID in dogs CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA’s June deadline – 51 dogs ...